• Profile
Close

Evaluation of a combined reflectance confocal microscopy–optical coherence tomography device for detection and depth assessment of basal cell carcinoma

JAMA Dermatology Aug 25, 2018

Sahu A, et al. - Authors ascertained the accuracy of a combined reflectance confocal microscopy (RCM)-optical coherence tomography (OCT) device for basal cell carcinoma (BCC) detection and deep margin assessment. Findings suggested a prospective use of combined RCM-OCT imaging to comprehensively diagnose lesions suggestive of BCC and triage for treatment, though further validation is required.

Methods

  • Researchers conducted a pilot study on 85 lesions from 55 patients referred for physician consultation or Mohs surgery at Memorial Sloan Kettering Skin Cancer Center in Hauppauge, NY.
  • They prospectively and consecutively enrolled these patients in the study between January 1, 2017, and December 31, 2017.
  • For previously biopsied, histopathologically confirmed BCCs and lesions clinically or dermoscopically suggestive of BCC, patients underwent imaging, with the combined RCM-OCT probe.
  • They only included the patients with available histopathologic examination after imaging.
  • They gauged the improvements in sensitivity, specificity, and diagnostic accuracy for BCC using the combined RCM-OCT probe as well as the correlation between OCT-estimated depth and histopathologically measured depth.

Results

  • In total, 85 lesions from 55 patients (27 [49%] were female and 28 [51%] were male with a median [range] age of 59 [21-90] years) were imaged.
  • Experts performed imaging on 25 previously biopsied and histopathologically confirmed BCCs and 60 previously nonbiopsied but clinically or dermoscopically suspicious lesions.
  • They correlated and validated the normal skin and BCC features with histopathologic examination.
  • As per data, in previously biopsied lesions, residual tumors were detected in 12 of 25 (48%) lesions with 100% sensitivity (95% CI, 73.5%-100%) and 23.1% specificity (95% CI, 5.0%-53.8%) for combined RCM-OCT probe.
  • They diagnosed BCCs in 48 of 60 (80%) lesions with 100% sensitivity (95% CI, 92.6%-100%) and 75% specificity (95% CI, 42.8%-94.5%) in previously nonbiopsied and suspicious lesions.
  • They observed association between depth estimated with OCT and depth measured with histopathologic examination: the coefficient of determination (R2) was 0.75 (R=0.86; P < .001) for all lesions, 0.73 (R=0.85; P< .001) for lesions less than 500 μm deep, and 0.65 (R=0.43;P < .001) for lesions greater than 500 μm deep.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay